BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022. [PMID: 32256705 DOI: 10.3332/ecancer.2020.1022] [Cited by in Crossref: 209] [Cited by in F6Publishing: 211] [Article Influence: 104.5] [Reference Citation Analysis]
Number Citing Articles
1 Hanna E. How fragile we are. Head Neck 2020;42:1125-30. [PMID: 32342575 DOI: 10.1002/hed.26199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Bagheri A, Moezzi SMI, Mosaddeghi P, Nadimi Parashkouhi S, Fazel Hoseini SM, Badakhshan F, Negahdaripour M. Interferon-inducer antivirals: Potential candidates to combat COVID-19. Int Immunopharmacol 2021;91:107245. [PMID: 33348292 DOI: 10.1016/j.intimp.2020.107245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
3 Dyavar SR, Singh R, Emani R, Pawar GP, Chaudhari VD, Podany AT, Avedissian SN, Fletcher CV, Salunke DB. Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options. Biomed Pharmacother 2021;141:111794. [PMID: 34153851 DOI: 10.1016/j.biopha.2021.111794] [Reference Citation Analysis]
4 Travi G, Rossotti R, Merli M, Sacco A, Perricone G, Lauterio A, Colombo VG, De Carlis L, Frigerio M, Minetti E, Belli LS, Puoti M. Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience. Am J Transplant 2020;20:2628-9. [PMID: 32436646 DOI: 10.1111/ajt.16069] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
5 Li X, Lin H, Wang Q, Cui L, Luo H, Luo L. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus pneumonia (COVID-19). Drug Dev Ind Pharm 2020;46:1947-59. [PMID: 33054436 DOI: 10.1080/03639045.2020.1826510] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Seo MR, Kim J, Park E, Jung SM, Sung Y, Kim H, Kim G, Kim H, Lee M, Lee J, Hur J, Chin BS, Eom JS, Baek HJ; The Korean College of Rheumatology Working Group. Recommendations for the Management of Patients With Systemic Rheumatic Diseases During the Coronavirus Disease Pandemic. J Rheum Dis 2020;27:218-32. [DOI: 10.4078/jrd.2020.27.4.218] [Reference Citation Analysis]
7 Hyder Pottoo F, Abu-Izneid T, Mohammad Ibrahim A, Noushad Javed M, AlHajri N, Hamrouni AM. Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19. Saudi Pharm J 2021;29:173-87. [PMID: 33519271 DOI: 10.1016/j.jsps.2020.12.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kwak-Kim J, Ota K, Sung N, Huang C, Alsubki L, Lee S, Han JW, Han A, Yang X, Saab W, Derbala Y, Wang WJ, He Q, Liao A, Takahashi T, Cavalcante MB, Barini R, Bao S, Fukui A, Lédée N, Coulam C. COVID-19 and immunomodulation treatment for women with reproductive failures. J Reprod Immunol 2020;141:103168. [PMID: 32603991 DOI: 10.1016/j.jri.2020.103168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
9 Ji HL, Liu C, Zhao RZ. Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials. World J Stem Cells 2020; 12(6): 471-480 [PMID: 32742564 DOI: 10.4252/wjsc.v12.i6.471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Alizadeh LS, Albrecht MH, Booz C. Radiographic case report of a heart transplanted patient suffering from COVID-19. Heliyon 2021;7:e06688. [PMID: 33842708 DOI: 10.1016/j.heliyon.2021.e06688] [Reference Citation Analysis]
11 Khan MA, Khan ZA, Charles M, Pratap P, Naeem A, Siddiqui Z, Naqvi N, Srivastava S. Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms. J Inflamm Res. 2021;14:175-189. [PMID: 33519225 DOI: 10.2147/jir.s271292] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
12 Irmak DK, Darıcı H, Karaöz E. Stem Cell Based Therapy Option in COVID-19: Is It Really Promising? Aging Dis 2020;11:1174-91. [PMID: 33014531 DOI: 10.14336/AD.2020.0608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
13 Hembram P. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021;45:123. [PMID: 34257504 DOI: 10.1186/s42269-021-00582-2] [Reference Citation Analysis]
14 Hage R, Steinack C, Benden C, Schuurmans M. COVID-19 in Patients with Solid Organ Transplantation: A Systematic Review. Transplantology 2020;1:1-15. [DOI: 10.3390/transplantology1010001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 7.5] [Reference Citation Analysis]
15 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46-64. [PMID: 33077917 DOI: 10.1038/s41581-020-00357-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 42.5] [Reference Citation Analysis]
16 Barré J, Sabatier JM, Annweiler C. Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence. Front Pharmacol 2020;11:1344. [PMID: 33013375 DOI: 10.3389/fphar.2020.01344] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Schreiber A, Elango K, Hong K, Ahsan C. Cardiac transplant recipient with COVID-19 induced acute hypoxic respiratory failure: a case report. Eur Heart J Case Rep 2021;5:ytab217. [PMID: 34189399 DOI: 10.1093/ehjcr/ytab217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Elahi R, Karami P, Heidary AH, Esmaeilzadeh A. An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19). International Immunopharmacology 2022;105:108536. [DOI: 10.1016/j.intimp.2022.108536] [Reference Citation Analysis]
19 Morlacchi LC, Rossetti V, Gigli L, Amati F, Rosso L, Aliberti S, Nosotti M, Blasi F. COVID‐19 in lung transplant recipients: A case series from Milan, Italy. Transpl Infect Dis 2020;22. [DOI: 10.1111/tid.13356] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
20 Lee H, Park J, Im HJ, Na KJ, Choi H. Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients. Sci Rep 2021;11:14151. [PMID: 34239034 DOI: 10.1038/s41598-021-93743-2] [Reference Citation Analysis]
21 Türsen Ü, Türsen B, Lotti T. Cutaneous sıde-effects of the potential COVID-19 drugs. Dermatol Ther 2020;33:e13476. [PMID: 32358890 DOI: 10.1111/dth.13476] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
22 Bahloul M, Ketata W, Lahyeni D, Mayoufi H, Kotti A, Smaoui F, Kallel N, Daoud E, Bouaziz M, Kammoun S. Pulmonary capillary leak syndrome following COVID-19 virus infection. J Med Virol. 2021;93:94-96. [PMID: 32519786 DOI: 10.1002/jmv.26152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
23 Su H, Wan C, Wang ZD, Gao Y, Li YC, Tang F, Zhu HY, Yi LX, Zhang C. Expression of CD147 and Cyclophilin A in Kidneys of Patients with COVID-19. Clin J Am Soc Nephrol 2021;16:618-9. [PMID: 33268502 DOI: 10.2215/CJN.09440620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kaffash Farkhad N, Reihani H, Sedaghat A, Moghadam AA, Moghadam AB, Tavakol-Afshari J. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies. Regen Ther 2021;18:152-60. [PMID: 34124322 DOI: 10.1016/j.reth.2021.05.007] [Reference Citation Analysis]
25 Hussain FS, Eldeeb MA, Blackmore D, Siddiqi ZA. Guillain Barré syndrome and COVID-19: Possible role of the cytokine storm. Autoimmun Rev 2020;19:102681. [PMID: 33099040 DOI: 10.1016/j.autrev.2020.102681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
26 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Reference Citation Analysis]
27 Imazio M, Brucato A, Lazaros G, Andreis A, Scarsi M, Klein A, De Ferrari GM, Adler Y. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality. Journal of Cardiovascular Medicine 2020;21:625-9. [DOI: 10.2459/jcm.0000000000001059] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 10.5] [Reference Citation Analysis]
28 Heldman MR, Kates OS. COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature. Curr Treat Options Infect Dis 2021;:1-16. [PMID: 34220357 DOI: 10.1007/s40506-021-00249-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Moosavi SA, Mashhadiagha A, Motazedian N, Hashemazar A, Hoveidaei AH, Bolignano D. COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis 2020;22:e13427. [PMID: 32779820 DOI: 10.1111/tid.13427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
30 Jani BD, Pell JP, McGagh D, Liyanage H, Kelly D, de Lusignan S, Weatherburn CJ, Burns R, Sullivan FM, Mair FS. Recording COVID-19 consultations: review of symptoms, risk factors, and proposed SNOMED CT terms. BJGP Open 2020;4:bjgpopen20X101125. [PMID: 32843331 DOI: 10.3399/bjgpopen20X101125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Russell B, Moss C, Papa S, Irshad S, Ross P, Spicer J, Kordasti S, Crawley D, Wylie H, Cahill F, Haire A, Zaki K, Rahman F, Sita-Lumsden A, Josephs D, Enting D, Lei M, Ghosh S, Harrison C, Swampillai A, Sawyer E, D'Souza A, Gomberg S, Fields P, Wrench D, Raj K, Gleeson M, Bailey K, Dillon R, Streetly M, Rigg A, Sullivan R, Dolly S, Van Hemelrijck M. Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London. Front Oncol 2020;10:1279. [PMID: 32903324 DOI: 10.3389/fonc.2020.01279] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
32 Abdul-Jawad S, Baù L, Alaguthurai T, Del Molino Del Barrio I, Laing AG, Hayday TS, Monin L, Muñoz-Ruiz M, McDonald L, Francos Quijorna I, McKenzie D, Davis R, Lorenc A, Chan JNE, Ryan S, Bugallo-Blanco E, Yorke R, Kamdar S, Fish M, Zlatareva I, Vantourout P, Jennings A, Gee S, Doores K, Bailey K, Hazell S, De Naurois J, Moss C, Russell B, Khan AA, Rowley M, Benjamin R, Enting D, Alrifai D, Wu Y, Zhou Y, Barber P, Ng T, Spicer J, Van Hemelrijck M, Kumar M, Vidler J, Lwin Y, Fields P, Karagiannis SN, Coolen ACC, Rigg A, Papa S, Hayday AC, Patten PEM, Irshad S. Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients. Cancer Cell 2021;39:257-275.e6. [PMID: 33476581 DOI: 10.1016/j.ccell.2021.01.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 23.0] [Reference Citation Analysis]
33 Singh VK, Mishra A, Singh S, Kumar P, Singh M, Jagannath C, Khan A. Emerging Prevention and Treatment Strategies to Control COVID-19. Pathogens 2020;9:E501. [PMID: 32585805 DOI: 10.3390/pathogens9060501] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
34 Esmaeilzadeh A, Elahi R. Immunobiology and immunotherapy of COVID-19: A clinically updated overview. J Cell Physiol 2021;236:2519-43. [PMID: 33022076 DOI: 10.1002/jcp.30076] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
35 Daoud A, Alqassieh A, Alkhader D, Posadas Salas MA, Rao V, Fülöp T, Soliman KM. Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading? Ren Fail 2021;43:273-80. [PMID: 33491531 DOI: 10.1080/0886022X.2021.1876730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Algara M, Arenas M, Marin J, Vallverdu I, Fernandez-Letón P, Villar J, Fabrer G, Rubio C, Montero A. Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial. Clin Transl Radiat Oncol 2020;24:29-33. [PMID: 32613089 DOI: 10.1016/j.ctro.2020.06.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
37 Williams A, Branscome H, Khatkar P, Mensah GA, Al Sharif S, Pinto DO, DeMarino C, Kashanchi F. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system. J Neurovirol 2021;27:667-90. [PMID: 34581996 DOI: 10.1007/s13365-021-00998-6] [Reference Citation Analysis]
38 Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes Metab Syndr 2020;14:1043-51. [PMID: 32640416 DOI: 10.1016/j.dsx.2020.06.056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
39 Feyaerts AF, Luyten W. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? Nutrition 2020;79-80:110948. [PMID: 32911430 DOI: 10.1016/j.nut.2020.110948] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
40 Cure E, Kucuk A, Cumhur Cure M. Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19). Rheumatol Int 2020;40:1177-9. [PMID: 32415310 DOI: 10.1007/s00296-020-04603-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
41 Dwivedy A, Mariadasse R, Ahmad M, Chakraborty S, Kar D, Tiwari S, Bhattacharyya S, Sonar S, Mani S, Tailor P, Majumdar T, Jeyakanthan J, Biswal BK, Schlessinger A. Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2. PLoS Comput Biol 2021;17:e1009384. [DOI: 10.1371/journal.pcbi.1009384] [Reference Citation Analysis]
42 Lee KH, Yoon S, Jeong GH, Kim JY, Han YJ, Hong SH, Ryu S, Kim JS, Lee JY, Yang JW, Lee J, Solmi M, Koyanagi A, Dragioti E, Jacob L, Radua J, Smith L, Oh H, Tizaoui K, Cargnin S, Terrazzino S, Ghayda RA, Kronbichler A, Shin JI. Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis. J Clin Med 2020;9:E2392. [PMID: 32726951 DOI: 10.3390/jcm9082392] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
43 Yarmohammadi A, Yarmohammadi M, Fakhri S, Khan H. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review. Eur J Pharmacol 2021;890:173620. [PMID: 33038418 DOI: 10.1016/j.ejphar.2020.173620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
44 Barbalho SM, Matias JN, Flato UAP, Pilon JPG, Bitelli P, Pagani Junior MA, de Carvalho ACA, Haber JFDS, Reis CHB, Goulart RA. What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease? Gastroenterology Res 2021;14:1-12. [PMID: 33737994 DOI: 10.14740/gr1358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Kridin K, Schonmann Y, Tzur Bitan D, Damiani G, Peretz A, Weinstein O, Cohen AD. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study. Am J Clin Dermatol 2021;22:709-18. [PMID: 34060006 DOI: 10.1007/s40257-021-00605-8] [Reference Citation Analysis]
46 Chang YY, Wang WH, Ku SW. Good response of low-dose steroid in a patient with COVID-19 pneumonia and autoimmune disease. J Microbiol Immunol Infect 2021;54:1001-2. [PMID: 34090821 DOI: 10.1016/j.jmii.2021.04.005] [Reference Citation Analysis]
47 Angelico R, Blasi F, Manzia TM, Toti L, Tisone G, Cacciola R. The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature. Medicina (Kaunas) 2021;57:435. [PMID: 33946462 DOI: 10.3390/medicina57050435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Sankar J, Dhochak N, Kabra SK, Lodha R. COVID-19 in Children: Clinical Approach and Management. Indian J Pediatr 2020;87:433-42. [PMID: 32338347 DOI: 10.1007/s12098-020-03292-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 17.5] [Reference Citation Analysis]
49 Rajaiah R, Abhilasha KV, Shekar MA, Vogel SN, Vishwanath BS. Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19. Cell Immunol 2020;358:104240. [PMID: 33137649 DOI: 10.1016/j.cellimm.2020.104240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Rammohan A. Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing. World J Transplant 2020; 10(9): 267-276 [PMID: 32995321 DOI: 10.5500/wjt.v10.i9.267] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
51 Citi V, Martelli A, Brancaleone V, Brogi S, Gojon G, Montanaro R, Morales G, Testai L, Calderone V. Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2 S donors in COVID-19 therapy. Br J Pharmacol 2020;177:4931-41. [PMID: 32783196 DOI: 10.1111/bph.15230] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
52 Rein N, Haham N, Orenbuch-Harroch E, Romain M, Argov Z, Vaknin-Dembinsky A, Gotkine M. Description of 3 patients with myasthenia gravis and COVID-19. J Neurol Sci 2020;417:117053. [PMID: 32731059 DOI: 10.1016/j.jns.2020.117053] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
53 Gundavda MK, Gundavda KK. Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic. SN Compr Clin Med 2020;:1-11. [PMID: 33251481 DOI: 10.1007/s42399-020-00632-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
54 Roongta R, Ghosh A. Managing rheumatoid arthritis during COVID-19. Clin Rheumatol 2020;39:3237-44. [PMID: 32892311 DOI: 10.1007/s10067-020-05358-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
55 Wang X, Gui J. Cell-mediated immunity to SARS-CoV-2. Pediatr Investig 2020;4:281-91. [PMID: 33376956 DOI: 10.1002/ped4.12228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
56 Rao KS, Suryaprakash V, Senthilkumar R, Preethy S, Katoh S, Ikewaki N, Abraham SJK. Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements. Front Immunol. 2020;11:1548. [PMID: 32733487 DOI: 10.3389/fimmu.2020.01548] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
57 Guo X, Kazanova A, Thurmond S, Saragovi HU, Rudd CE. Effective chimeric antigen receptor T cells against SARS-CoV-2. iScience 2021;24:103295. [PMID: 34693218 DOI: 10.1016/j.isci.2021.103295] [Reference Citation Analysis]
58 Migo W, Boskovic M, Likic R. The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response. Curr Res Pharmacol Drug Discov 2021;2:100064. [PMID: 34870159 DOI: 10.1016/j.crphar.2021.100064] [Reference Citation Analysis]
59 Pantazi I, Al-Qahtani AA, Alhamlan FS, Alothaid H, Matou-Nasri S, Sourvinos G, Vergadi E, Tsatsanis C. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages. Front Immunol 2021;12:683800. [PMID: 34248968 DOI: 10.3389/fimmu.2021.683800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Becchetti C, Zambelli MF, Pasulo L, Donato MF, Invernizzi F, Detry O, Dahlqvist G, Ciccarelli O, Morelli MC, Fraga M, Svegliati-Baroni G, van Vlierberghe H, Coenraad MJ, Romero MC, de Gottardi A, Toniutto P, Del Prete L, Abbati C, Samuel D, Pirenne J, Nevens F, Dufour JF;  COVID-LT group. COVID-19 in an international European liver transplant recipient cohort. Gut. 2020;69:1832-1840. [PMID: 32571972 DOI: 10.1136/gutjnl-2020-321923] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 30.5] [Reference Citation Analysis]
61 Waleed RM, Sehar I, Iftikhar W, Khan HS. Hematologic parameters in coronavirus infection (COVID-19) and their clinical implications. Discoveries (Craiova) 2020;8:e117. [PMID: 33110936 DOI: 10.15190/d.2020.14] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Seo MR, Kim JW, Park EJ, Jung SM, Sung YK, Kim H, Kim G, Kim HS, Lee MS, Lee J, Hur JA, Chin BS, Eom JS, Baek HJ; Korean College of Rheumatology working group. Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic. Korean J Intern Med 2020;35:1317-32. [PMID: 32972125 DOI: 10.3904/kjim.2020.417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 de Cáceres C, Martínez R, Bachiller P, Marín L, García JM. The effect of tocilizumab on cytokine release syndrome in COVID-19 patients. Pharmacol Rep 2020;72:1529-37. [PMID: 33165762 DOI: 10.1007/s43440-020-00186-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
64 Cabbab ILN, Manalo RVM. Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection. Virus Res 2021;291:198190. [PMID: 33039544 DOI: 10.1016/j.virusres.2020.198190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Little CP, Birks ME, Horwitz MD, Ng CY, Warwick D. COVID-19: A rethink of corticosteroid injection? Bone Jt Open 2020;1:253-6. [PMID: 33225297 DOI: 10.1302/2633-1462.16.BJO-2020-0050.R1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
66 Santos J, Brierley S, Gandhi MJ, Cohen MA, Moschella PC, Declan ABL. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review. Viruses 2020;12:E705. [PMID: 32629804 DOI: 10.3390/v12070705] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
67 Tian Y, Qiu X, Wang C, Zhao J, Jiang X, Niu W, Huang J, Zhang F. Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis. Int J Cancer 2021;148:363-74. [PMID: 32683687 DOI: 10.1002/ijc.33213] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
68 Mehta Y, Dixit SB, Zirpe KG, Ansari AS. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations. Indian J Crit Care Med 2020;24:429-34. [PMID: 32863636 DOI: 10.5005/jp-journals-10071-23415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
69 Gisondi P, Piaserico S, Naldi L, Dapavo P, Conti A, Malagoli P, Marzano AV, Bardazzi F, Gasperini M, Cazzaniga S, Costanzo A; collaborators in the studies of COVID-19 pandemic. Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience. J Allergy Clin Immunol 2021;147:558-560.e1. [PMID: 33160968 DOI: 10.1016/j.jaci.2020.10.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
70 Alola AA, Olowu FB. The health scare of COVID-19 amidst pandemics and the immune-related pharmaceutical products spillovers in the USA. Environ Sci Pollut Res Int 2020;27:45949-56. [PMID: 33064278 DOI: 10.1007/s11356-020-11195-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
71 Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med 2021;16:1123-9. [PMID: 33484452 DOI: 10.1007/s11739-021-02635-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
72 Sabeerabi B, Vemula S, Vadde R, Nagaraju GP. COVID-19: Where is the treatment? World J Clin Oncol 2021; 12(5): 309-322 [PMID: 34131563 DOI: 10.5306/wjco.v12.i5.309] [Reference Citation Analysis]
73 Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child 2020:archdischild-2020-320338. [PMID: 33262177 DOI: 10.1136/archdischild-2020-320338] [Cited by in Crossref: 50] [Cited by in F6Publishing: 61] [Article Influence: 25.0] [Reference Citation Analysis]
74 Remy KE, Mazer M, Striker DA, Ellebedy AH, Walton AH, Unsinger J, Blood TM, Mudd PA, Yi DJ, Mannion DA, Osborne DF, Martin RS, Anand NJ, Bosanquet JP, Blood J, Drewry AM, Caldwell CC, Turnbull IR, Brakenridge SC, Moldwawer LL, Hotchkiss RS. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight 2020;5:140329. [PMID: 32687484 DOI: 10.1172/jci.insight.140329] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 47.0] [Reference Citation Analysis]
75 Lauterio A, Valsecchi M, Santambrogio S, De Carlis R, Merli M, Calini A, Centonze L, Buscemi V, Bottiroli M, Puoti M, Fumagalli R, De Carlis L. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis. 2020;e13334. [PMID: 32449235 DOI: 10.1111/tid.13334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
76 Antony SJ, Singh J, de Jesus M, Lance J. Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation. IDCases 2020;21:e00888. [PMID: 32685369 DOI: 10.1016/j.idcr.2020.e00888] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
77 van Dam PA, Huizing M, Mestach G, Dierckxsens S, Tjalma W, Trinh XB, Papadimitriou K, Altintas S, Vermorken J, Vulsteke C, Janssens A, Berneman Z, Prenen H, Meuris L, Vanden Berghe W, Smits E, Peeters M. SARS-CoV-2 and cancer: Are they really partners in crime? Cancer Treat Rev 2020;89:102068. [PMID: 32731090 DOI: 10.1016/j.ctrv.2020.102068] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 16.0] [Reference Citation Analysis]
78 Arora H, Boothby-Shoemaker W, Braunberger T, Lim HW, Veenstra J. Safety of conventional immunosuppressive therapies for patients with dermatological conditions and coronavirus disease 2019: A review of current evidence. J Dermatol 2021. [PMID: 34962304 DOI: 10.1111/1346-8138.16182] [Reference Citation Analysis]
79 Solanich X, Antolí A, Rocamora-Blanch G, Padullés N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Riera-Mestre A, Bas J, Vicens-Zygmunt V, Niubó J, Calvo N, Bolivar S, Rigo-Bonnin R, Mensa-Vilaró A, Arregui L, Tebe C, Videla S, Hereu P, Corbella X. Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial. Front Med (Lausanne) 2021;8:691712. [PMID: 34195214 DOI: 10.3389/fmed.2021.691712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Singh SP, Pritam M, Pandey B, Yadav TP. Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review. J Med Virol 2021;93:275-99. [PMID: 32617987 DOI: 10.1002/jmv.26254] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
81 Quan C, Li C, Ma H, Li Y, Zhang H. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis. Clin Microbiol Rev 2020;34:e00074-20. [PMID: 33055229 DOI: 10.1128/CMR.00074-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
82 Penman SL, Kiy RT, Jensen RL, Beoku-Betts C, Alfirevic A, Back D, Khoo SH, Owen A, Pirmohamed M, Park BK, Meng X, Goldring CE, Chadwick AE. Safety perspectives on presently considered drugs for the treatment of COVID-19. Br J Pharmacol 2020;177:4353-74. [PMID: 32681537 DOI: 10.1111/bph.15204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Ozieranski K, Tyminska A, Jonik S, Marcolongo R, Baritussio A, Grabowski M, Filipiak KJ, Opolski G, Caforio ALP. Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction? J Card Fail 2021;27:92-6. [PMID: 33166657 DOI: 10.1016/j.cardfail.2020.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Pandolfi S, Chirumbolo S, Ricevuti G, Valdenassi L, Bjørklund G, Lysiuk R, Doşa MD, Lenchyk L, Fazio S. Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal. Basic Clin Pharmacol Toxicol 2021. [PMID: 34811895 DOI: 10.1111/bcpt.13690] [Reference Citation Analysis]
85 de Moraes ÉB, Santos Garcia JB, de Macedo Antunes J, Daher DV, Seixas FL, Muniz Ferrari MF. Chronic Pain Management during the Covid-19 Pandemic: A Scoping Review. Pain Manag Nurs 2021;22:103-10. [PMID: 33390355 DOI: 10.1016/j.pmn.2020.11.010] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
86 Foss FM, Rubinowitz A, Landry ML, Isufi I, Gowda L, Seropian S, Perreault S, Shenoi SV. Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib. Clin Lymphoma Myeloma Leuk 2020;20:720-3. [PMID: 32727701 DOI: 10.1016/j.clml.2020.06.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
87 Thakur S, Mayank, Sarkar B, Ansari AJ, Khandelwal A, Arya A, Poduri R, Joshi G. Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update. Food Chem Toxicol 2021;147:111887. [PMID: 33253764 DOI: 10.1016/j.fct.2020.111887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Samimagham HR, Arabi M, Hooshyar D, Kazemijahromi M. The Association of Non-Steroidal Anti-Inflammatory Drugs with COVID-19 Severity and Mortality. Arch Clin Infect Dis 2020;15. [DOI: 10.5812/archcid.106847] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
89 Bahari Z, Jangravi Z, Ghoshooni H, Afarinesh MR, Meftahi GH. Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection. Inflamm Res 2021;70:389-405. [PMID: 33608746 DOI: 10.1007/s00011-021-01445-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Smail SW, Saeed M, Twana Alkasalias, Khudhur ZO, Younus DA, Rajab MF, Abdulahad WH, Hussain HI, Niaz K, Safdar M. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review. Food Chem Toxicol 2021;150:112087. [PMID: 33640537 DOI: 10.1016/j.fct.2021.112087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Aghdam R, Habibi M, Taheri G. Using informative features in machine learning based method for COVID-19 drug repurposing. J Cheminform 2021;13:70. [PMID: 34544500 DOI: 10.1186/s13321-021-00553-9] [Reference Citation Analysis]
92 Park R, Lee SA, Kim SY, de Melo AC, Kasi A. Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data. Acta Oncologica 2021;60:13-9. [DOI: 10.1080/0284186x.2020.1837946] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
93 Kanimozhi G, Pradhapsingh B, Singh Pawar C, Khan HA, Alrokayan SH, Prasad NR. SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models. Front Pharmacol 2021;12:638334. [PMID: 33967772 DOI: 10.3389/fphar.2021.638334] [Reference Citation Analysis]
94 Santos A, Sousa LL, Calça R, Lima A, Nascimento C, Jorge C, Adragão T, Bruges M, Peres S, Weigert A. SARS-CoV-2 infection in kidney transplant recipients: clinical impact and outcomes - a single center experience. J Bras Nefrol 2021:S0101-28002021005078301. [PMID: 34812470 DOI: 10.1590/2175-8239-JBN-2021-0164] [Reference Citation Analysis]
95 Silva TF, Tomiotto-Pellissier F, Sanfelice RA, Gonçalves MD, da Silva Bortoleti BT, Detoni MB, Rodrigues ACJ, Carloto ACM, Concato VM, Siqueira EDS, Costa IN, Pavanelli WR, Conchon-Costa I, Miranda-Sapla MM. A 21st Century Evil: Immunopathology and New Therapies of COVID-19. Front Immunol 2020;11:562264. [PMID: 33193331 DOI: 10.3389/fimmu.2020.562264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
96 Paniri A, Akhavan-Niaki H. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation. Life Sci 2020;257:118114. [PMID: 32693241 DOI: 10.1016/j.lfs.2020.118114] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
97 Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, Souayah N. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations. Cytokine 2021;138:155404. [PMID: 33360025 DOI: 10.1016/j.cyto.2020.155404] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
98 Mir JM, Khan MW, Shalla AH, Maurya RC. A Nonclinical Spectroscopic Approach for Diagnosing Covid-19: A Concise Perspective. J Appl Spectrosc 2021;:1-7. [PMID: 34538886 DOI: 10.1007/s10812-021-01238-9] [Reference Citation Analysis]
99 Owji H, Negahdaripour M, Hajighahramani N. Immunotherapeutic approaches to curtail COVID-19. Int Immunopharmacol 2020;88:106924. [PMID: 32877828 DOI: 10.1016/j.intimp.2020.106924] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
100 Patrinely JR, Johnson DB. Pandemic medicine: the management of advanced melanoma during COVID-19. Melanoma Manag 2020;7:MMT45. [PMID: 32922727 DOI: 10.2217/mmt-2020-0012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
101 Tan SHS, Hong CC, Saha S, Murphy D, Hui JH. Medications in COVID-19 patients: summarizing the current literature from an orthopaedic perspective. Int Orthop 2020;44:1599-603. [PMID: 32445030 DOI: 10.1007/s00264-020-04643-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
102 Kassem DH, Kamal MM. Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis. Front Cell Dev Biol 2020;8:587866. [PMID: 33102489 DOI: 10.3389/fcell.2020.587866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
103 Abir T, Kalimullah NA, Osuagwu UL, Yazdani DMN, Mamun AA, Husain T, Basak P, Permarupan PY, Agho KE. Factors Associated with the Perception of Risk and Knowledge of Contracting the SARS-Cov-2 among Adults in Bangladesh: Analysis of Online Surveys. Int J Environ Res Public Health 2020;17:E5252. [PMID: 32708161 DOI: 10.3390/ijerph17145252] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
104 Neto LO, Tavares VDO, Galvão-Coelho NL, Schuch FB, Lima KC. Aging and Coronavirus: Exploring Complementary Therapies to Avoid Inflammatory Overload. Front Med (Lausanne) 2020;7:354. [PMID: 32714936 DOI: 10.3389/fmed.2020.00354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
105 George I, Salna M, Kobsa S, Deroo S, Kriegel J, Blitzer D, Shea NJ, D'Angelo A, Raza T, Kurlansky P, Takeda K, Takayama H, Bapat V, Naka Y, Smith CR, Bacha E, Argenziano M. The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a centre at the epicentre. Eur J Cardiothorac Surg 2020;58:667-75. [PMID: 32573737 DOI: 10.1093/ejcts/ezaa228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
106 Abdullah SF, Sharquie IK. SARS-CoV-2: A Piece of Bad News. Medeni Med J 2020;35:151-60. [PMID: 32733765 DOI: 10.5222/MMJ.2020.82584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Jack D, Nolting A, Galazka A. Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets. Mult Scler Relat Disord 2020;46:102469. [PMID: 32919180 DOI: 10.1016/j.msard.2020.102469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
108 Paces J, Strizova Z, Smrz D, Cerny J. COVID-19 and the immune system. Physiol Res 2020;69:379-88. [PMID: 32469225 DOI: 10.33549/physiolres.934492] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 34.5] [Reference Citation Analysis]
109 Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: Friend or foe? Life Sci 2020;256:117900. [PMID: 32502542 DOI: 10.1016/j.lfs.2020.117900] [Cited by in Crossref: 101] [Cited by in F6Publishing: 94] [Article Influence: 50.5] [Reference Citation Analysis]
110 Mohseni Afshar Z, Hosseinzadeh R, Barary M, Ebrahimpour S, Alijanpour A, Sayad B, Hosseinzadeh D, Miri SR, Sio TT, Sullman MJM, Carson-Chahhoud K, Babazadeh A. Challenges posed by COVID-19 in cancer patients: A narrative review. Cancer Med 2021. [PMID: 34951152 DOI: 10.1002/cam4.4519] [Reference Citation Analysis]
111 Shu Z, Zhou Y, Chang K, Liu J, Min X, Zhang Q, Sun J, Xiong Y, Zou Q, Zheng Q, Ji J, Poon J, Liu B, Zhou X, Li X. Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases. Front Med 2020;14:760-75. [PMID: 32926319 DOI: 10.1007/s11684-020-0803-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
112 Grabbe S, Beissert S, Enk A. Systemic immunosuppression in times of COVID-19: Do we need to rethink our standards? J Dtsch Dermatol Ges 2020;18:810-3. [PMID: 32743938 DOI: 10.1111/ddg.14194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
113 Battisti NML, Mislang AR, Cooper L, O'Donovan A, Audisio RA, Cheung KL, Sarrió RG, Stauder R, Soto-Perez-de-Celis E, Jaklitsch M, Williams GR, O'Hanlon S, Alam M, Cairo C, Colloca G, Gil LA Jr, Sattar S, Kantilal K, Russo C, Lichtman SM, Brain E, Kanesvaran R, Wildiers H. Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group. J Geriatr Oncol 2020;11:1190-8. [PMID: 32709495 DOI: 10.1016/j.jgo.2020.07.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
114 Ragni E, Mangiavini L, Viganò M, Brini AT, Peretti GM, Banfi G, de Girolamo L. Management of Osteoarthritis During the COVID-19 Pandemic. Clin Pharmacol Ther 2020;108:719-29. [PMID: 32438454 DOI: 10.1002/cpt.1910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
115 Wang ZZ, Li K, Maskey AR, Huang W, Toutov AA, Yang N, Srivastava K, Geliebter J, Tiwari R, Miao M, Li XM. A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study. FASEB J 2021;35:e21360. [PMID: 33749932 DOI: 10.1096/fj.202001792R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Abdel‐moneim A. COVID ‐19 complications on the digestive system and liver: A current clinical and pathophysiological approach. Adv in Digestive Med. [DOI: 10.1002/aid2.13260] [Reference Citation Analysis]
117 Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and Cancer: a Comprehensive Review. Curr Oncol Rep. 2020;22:53. [PMID: 32385672 DOI: 10.1007/s11912-020-00934-7] [Cited by in Crossref: 108] [Cited by in F6Publishing: 101] [Article Influence: 54.0] [Reference Citation Analysis]
118 Laborie E, Le-Minh V, Mai TD, Ammar M, Taverna M, Smadja C. Analytical methods of antibody surface coverage and orientation on bio-functionalized magnetic beads: application to immunocapture of TNF-α. Anal Bioanal Chem 2021;413:6425-34. [PMID: 34401927 DOI: 10.1007/s00216-021-03608-w] [Reference Citation Analysis]
119 Ahluwalia M, Givertz MM, Mehra MR. A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19. Clin Transplant 2020;34:e14032. [PMID: 32621523 DOI: 10.1111/ctr.14032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
120 Manto M, Dupre N, Hadjivassiliou M, Louis ED, Mitoma H, Molinari M, Shaikh AG, Soong BW, Strupp M, Van Overwalle F, Schmahmann JD. Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications. Cerebellum 2020;19:562-8. [PMID: 32405955 DOI: 10.1007/s12311-020-01139-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
121 Carey SA, Afzal A, Jamil A, Williams S, Gottlieb RL. Outpatient COVID-19 surveillance testing in orthotopic heart transplant recipients. Clin Transplant 2020;34:e14105. [PMID: 32978777 DOI: 10.1111/ctr.14105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
122 de Oliveira PG, Termini L, Durigon EL, Lepique AP, Sposito AC, Boccardo E. Diacerein: A potential multi-target therapeutic drug for COVID-19. Med Hypotheses 2020;144:109920. [PMID: 32534337 DOI: 10.1016/j.mehy.2020.109920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
123 Fakhri S, Nouri Z, Moradi SZ, Akkol EK, Piri S, Sobarzo-Sánchez E, Farzaei MH, Echeverría J. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates. Molecules 2021;26:2917. [PMID: 34068970 DOI: 10.3390/molecules26102917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Karruli A, Spiezia S, Boccia F, Gagliardi M, Patauner F, Salemme A, Maiello C, Zampino R, Durante-Mangoni E. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis. Transpl Infect Dis 2021;:e13595. [PMID: 33641202 DOI: 10.1111/tid.13595] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
125 Dwivedy A, Mariadasse R, Ahmad M, Chakraborty S, Kar D, Tiwari S, Bhattacharyya S, Sonar S, Mani S, Tailor P, Majumdar T, Jeyakanthan J, Biswal BK. Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2. PLoS Comput Biol 2021;17:e1009384. [PMID: 34516563 DOI: 10.1371/journal.pcbi.1009384] [Reference Citation Analysis]
126 Nowroozi A, Razi S, Sahu KK, Grizzi F, Arends J, Keshavarz-Fathi M, Rezaei N. COVID-19 in Patients with Cancer. Adv Exp Med Biol 2021;1318:315-31. [PMID: 33973186 DOI: 10.1007/978-3-030-63761-3_18] [Reference Citation Analysis]
127 Shahgolzari M, Yavari A, Arjeini Y, Miri SM, Darabi A, Mozaffari Nejad AS, Keshavarz M. Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn. Gene Rep 2021;25:101417. [PMID: 34778602 DOI: 10.1016/j.genrep.2021.101417] [Reference Citation Analysis]
128 Ghasemnejad-Berenji M, Pashapour S, Sadeghpour S. Pentoxifylline: A Drug with Antiviral and Anti-Inflammatory Effects to Be Considered in the Treatment of Coronavirus Disease 2019. Med Princ Pract 2021;30:98-100. [PMID: 33049737 DOI: 10.1159/000512234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Bayat M, Asemani Y, Mohammadi MR, Sanaei M, Namvarpour M, Eftekhari R. An overview of some potential immunotherapeutic options against COVID-19. Int Immunopharmacol 2021;95:107516. [PMID: 33765610 DOI: 10.1016/j.intimp.2021.107516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Solanich X, Antolí A, Padullés N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Molina M, Sabater J, Bas J, Mensa-Vilaró A, Niubó J, Calvo N, Bolivar S, Rigo-Bonnin R, Arregui L, Tebé C, Hereu P, Videla S, Corbella X. Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol. Contemp Clin Trials Commun 2021;21:100716. [PMID: 33495742 DOI: 10.1016/j.conctc.2021.100716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
131 Kocak B, Arpali E, Akyollu B, Yelken B, Tekin S, Kanbay M, Turkmen A, Kalayoglu M. Oligosymptomatic Kidney Transplant Patients With COVID-19: Do They Pose a Risk to Other Recipients? Transplant Proc 2020;52:2663-6. [PMID: 32419709 DOI: 10.1016/j.transproceed.2020.05.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
132 Manivannan S, Ponnuchamy K. Quantum dots as a promising agent to combat COVID-19. Appl Organomet Chem 2020;:e5887. [PMID: 32836625 DOI: 10.1002/aoc.5887] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
133 Deb S, Arrighi S. Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients. Eur J Drug Metab Pharmacokinet 2021;46:185-203. [PMID: 33538960 DOI: 10.1007/s13318-020-00668-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
134 Metzl JD, McElheny K, Robinson JN, Scott DA, Sutton KM, Toresdahl BG. Considerations for Return to Exercise Following Mild-to-Moderate COVID-19 in the Recreational Athlete. HSS J 2020;:1-6. [PMID: 32837412 DOI: 10.1007/s11420-020-09777-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
135 Parent B, Yang YT, Caplan A. "Should Patients Who Refuse COVID Vaccination Be Denied Transplantation Eligibility?". J Card Fail 2022:S1071-9164(22)00047-1. [PMID: 35150871 DOI: 10.1016/j.cardfail.2022.02.001] [Reference Citation Analysis]
136 Mardi A, Meidaninikjeh S, Nikfarjam S, Majidi Zolbanin N, Jafari R. Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective. Viral Immunol 2021;34:679-88. [PMID: 34882013 DOI: 10.1089/vim.2021.0071] [Reference Citation Analysis]
137 Fatima N, Sheikh N, Satoskar AR, Akhtar T, Tayyeb A, Ashfaq I, Ryan N, Ambreen S, Jha BK, Oghumu S. Effect of Short-Term Tacrolimus Exposure on Rat Liver: An Insight into Serum Antioxidant Status, Liver Lipid Peroxidation, and Inflammation. Mediators Inflamm 2021;2021:6613786. [PMID: 33679236 DOI: 10.1155/2021/6613786] [Reference Citation Analysis]
138 Savla SR, Prabhavalkar KS, Bhatt LK. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Rev Anti Infect Ther 2021;:1-17. [PMID: 33832398 DOI: 10.1080/14787210.2021.1915129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
139 Shahidi Dadras M, Namazi N, Nikvar M, Abdollahimajd F. Challenges faced by patients with morphea in the era of SARS-CoV-2. J Dermatolog Treat 2020;:1-2. [PMID: 32502370 DOI: 10.1080/09546634.2020.1775771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Gupta A, Marzook H, Ahmad F. Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview. Clin Exp Med 2022. [PMID: 35362771 DOI: 10.1007/s10238-022-00821-4] [Reference Citation Analysis]
141 Luban J, Sattler RA, Mühlberger E, Graci JD, Cao L, Weetall M, Trotta C, Colacino JM, Bavari S, Strambio-De-Castillia C, Suder EL, Wang Y, Soloveva V, Cintron-Lue K, Naryshkin NA, Pykett M, Welch EM, O'Keefe K, Kong R, Goodwin E, Jacobson A, Paessler S, Peltz SW. The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines. Virus Res 2021;292:198246. [PMID: 33249060 DOI: 10.1016/j.virusres.2020.198246] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
142 Aigner L, Pietrantonio F, Bessa de Sousa DM, Michael J, Schuster D, Reitsamer HA, Zerbe H, Studnicka M. The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic. Front Mol Biosci 2020;7:610132. [PMID: 33392263 DOI: 10.3389/fmolb.2020.610132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
143 Wang AX, Quintero Cardona O, Ho DY, Busque S, Lenihan CR. Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients. Transpl Infect Dis 2021;23:e13423. [PMID: 32701196 DOI: 10.1111/tid.13423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
144 Bruce E, Barlow-Pay F, Short R, Vilches-Moraga A, Price A, McGovern A, Braude P, Stechman MJ, Moug S, McCarthy K, Hewitt J, Carter B, Myint PK. Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19. J Clin Med 2020;9:E2586. [PMID: 32785086 DOI: 10.3390/jcm9082586] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
145 Nitulescu GM, Paunescu H, Moschos SA, Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK, Drakoulis N, Tsatsakis A. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review). Int J Mol Med 2020;46:467-88. [PMID: 32468014 DOI: 10.3892/ijmm.2020.4608] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 23.0] [Reference Citation Analysis]
146 Gapud EJ, Kronbichler A, Gauckler P, Geetha D. Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic. Eur J Rheumatol 2020;7:S121-8. [PMID: 32716836 DOI: 10.5152/eurjrheum.2020.2067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
147 Steinack C, Hage R, Benden C, Schuurmans M. SARS-CoV-2 and Norovirus Co-Infection after Lung Transplantation. Transplantology 2020;1:16-23. [DOI: 10.3390/transplantology1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
148 Chi G, Memar Montazerin S, Lee JJ, Kazmi SHA, Shojaei F, Fitzgerald C, Gibson CM. Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials. J Med Virol 2021. [PMID: 34370328 DOI: 10.1002/jmv.27259] [Reference Citation Analysis]
149 Çolak S, Tekgöz E, Çinar M, Yilmaz G, Tecer D, Biçakçi F, Cuce F, Fidan G, Doğan D, Savaşçi Ü, Arslan Y, Taşçi C, Uyar E, Karacaer Z, Şenkal S, Yilmaz S. Efficacy of tocilizumab in severe COVID-19: a retrospective study. Journal of Health Sciences and Medicine 2022;5:592-9. [DOI: 10.32322/jhsm.1064728] [Reference Citation Analysis]
150 Kaddoura M, AlIbrahim M, Hijazi G, Soudani N, Audi A, Alkalamouni H, Haddad S, Eid A, Zaraket H. COVID-19 Therapeutic Options Under Investigation. Front Pharmacol 2020;11:1196. [PMID: 32848795 DOI: 10.3389/fphar.2020.01196] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
151 Wondmkun YT, Mohammed OA. A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment. Biologics 2020;14:77-82. [PMID: 32921981 DOI: 10.2147/BTT.S266487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
152 Lotfi R, Kalmarzi RN, Roghani SA. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2). Immunol Res 2021;69:213-24. [PMID: 33928531 DOI: 10.1007/s12026-021-09198-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Paltrinieri S, Giordano A, Stranieri A, Lauzi S. Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID-19): Are they similar? Transbound Emerg Dis 2021;68:1786-99. [PMID: 32985113 DOI: 10.1111/tbed.13856] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
154 Gálvez-Romero JL, Palmeros-Rojas O, Real-Ramírez FA, Sánchez-Romero S, Tome-Maxil R, Ramírez-Sandoval MP, Olivos-Rodríguez R, Flores-Encarnación SE, Cabrera-Estrada AA, Ávila-Morales J, Cortés-Sánchez V, Sarmiento-Padilla G, Tezmol-Ramírez SE, Aparicio-Hernández D, Urbina-Sánchez MI, Gómez-Pluma MÁ, Cisneros-Méndez S, Rodríguez-Rivas DI, Reyes-Inurrigarro S, Cortés-Díaz G, Cruz-Delgado C, Navarro-González J, Deveaux-Homs J, Pedraza-Sánchez S. Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: A pilot study. J Intern Med 2021;289:906-20. [PMID: 33274479 DOI: 10.1111/joim.13223] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
155 Morena V, Milazzo L, Oreni L, Bestetti G, Fossali T, Bassoli C, Torre A, Cossu MV, Minari C, Ballone E, Perotti A, Mileto D, Niero F, Merli S, Foschi A, Vimercati S, Rizzardini G, Sollima S, Bradanini L, Galimberti L, Colombo R, Micheli V, Negri C, Ridolfo AL, Meroni L, Galli M, Antinori S, Corbellino M. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med. 2020;76:36-42. [PMID: 32448770 DOI: 10.1016/j.ejim.2020.05.011] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 52.5] [Reference Citation Analysis]
156 Benedetti C, Waldman M, Zaza G, Riella LV, Cravedi P. COVID-19 and the Kidneys: An Update. Front Med (Lausanne) 2020;7:423. [PMID: 32793615 DOI: 10.3389/fmed.2020.00423] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 14.5] [Reference Citation Analysis]
157 Lin HXJ, Cho S, Meyyur Aravamudan V, Sanda HY, Palraj R, Molton JS, Venkatachalam I. Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence. Infection 2021;49:401-10. [PMID: 33389708 DOI: 10.1007/s15010-020-01557-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
158 Afshar Z, Babazadeh A, Javanian M, Barary M, Rekha V, Ebrahimpour S. A comprehensive review of COVID-19 treatment. Acta fac medic Naissensis 2021;38:105-15. [DOI: 10.5937/afmnai38-26326] [Reference Citation Analysis]
159 Stephens AJ, Barton JR, Bentum NA, Blackwell SC, Sibai BM. General Guidelines in the Management of an Obstetrical Patient on the Labor and Delivery Unit during the COVID-19 Pandemic. Am J Perinatol 2020;37:829-36. [PMID: 32344441 DOI: 10.1055/s-0040-1710308] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
160 Al-tannak NF, Novotny L, Alhunayan A. Remdesivir—Bringing Hope for COVID-19 Treatment. Sci Pharm 2020;88:29. [DOI: 10.3390/scipharm88020029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
161 Peeler KR, Puccetti D, Lamb GS, Nguyen AA, Roberts J, Trissal M, McAlvin JB. Cytokine Storm Unmasks Immunodeficiency in a Child With Severe COVID-19. Clin Pediatr (Phila) 2021;60:205-9. [PMID: 33682482 DOI: 10.1177/0009922821999469] [Reference Citation Analysis]
162 Patel S, Saxena B, Mehta P. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19. Heliyon 2021;7:e06158. [PMID: 33553708 DOI: 10.1016/j.heliyon.2021.e06158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
163 Watzky M, de Dieuleveult M, Letessier A, Saint-Ruf C, Miotto B. Assessing the consequences of environmental exposures on the expression of the human receptor and proteases involved in SARS-CoV-2 cell-entry. Environ Res 2021;195:110317. [PMID: 33069705 DOI: 10.1016/j.envres.2020.110317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 El Kantar S, Nehmeh B, Saad P, Mitri G, Estephan C, Mroueh M, Akoury E, Taleb RI. Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites. Drug Discov Today 2020:S1359-6446(20)30307-X. [PMID: 32801052 DOI: 10.1016/j.drudis.2020.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
165 Georgiev T, Angelov AK. Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression. World J Clin Cases 2020; 8(17): 3669-3678 [PMID: 32953843 DOI: 10.12998/wjcc.v8.i17.3669] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
166 Barlow-Pay F, Htut TW, Khezrian M, Myint PK. Systematic review of immunosuppressant guidelines in the COVID-19 pandemic. Ther Adv Drug Saf 2021;12:2042098620985687. [PMID: 33628418 DOI: 10.1177/2042098620985687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
167 Baek WK, Sohn SY, Mahgoub A, Hage R. A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2. Cureus 2020;12:e7943. [PMID: 32499983 DOI: 10.7759/cureus.7943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
168 Hushmandi K, Bokaie S, Hashemi M, Moghadam ER, Raei M, Hashemi F, Bagheri M, Habtemariam S, Nabavi SM. A review of medications used to control and improve the signs and symptoms of COVID-19 patients. Eur J Pharmacol 2020;887:173568. [PMID: 32956644 DOI: 10.1016/j.ejphar.2020.173568] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 Bajpai D, Saxena N, Gandhi C, Modi T, Bose S, Deb S, Rao N, Kumar K, Katyal A, Patil A, Thakare S, Pajai AE, Haridas A, Keskar VS, Jawale SY, Sultan AG, Jamale TE. Does COVID-19 increase tacrolimus levels in kidney transplant recipients? J Clin Pharm Ther 2021. [PMID: 34951043 DOI: 10.1111/jcpt.13586] [Reference Citation Analysis]
170 Planchuelo-Gómez Á, Trigo J, de Luis-García R, Guerrero ÁL, Porta-Etessam J, García-Azorín D. Deep Phenotyping of Headache in Hospitalized COVID-19 Patients via Principal Component Analysis. Front Neurol 2020;11:583870. [PMID: 33391152 DOI: 10.3389/fneur.2020.583870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
171 Değirmenci MFK, Yalçındağ FN, Tugal-Tutkun İ. COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology. Turk J Ophthalmol 2021;51:231-42. [PMID: 34461710 DOI: 10.4274/tjo.galenos.2021.68252] [Reference Citation Analysis]
172 Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications. J Dtsch Dermatol Ges 2020;18:795-807. [PMID: 32761894 DOI: 10.1111/ddg.14169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
173 Pujari R, Thommana MV, Ruiz Mercedes B, Serwat A. Therapeutic Options for COVID-19: A Review. Cureus 2020;12:e10480. [PMID: 32953365 DOI: 10.7759/cureus.10480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
174 Lukan N. "Cytokine storm", not only in COVID-19 patients. Mini-review. Immunol Lett 2020;228:38-44. [PMID: 33007369 DOI: 10.1016/j.imlet.2020.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
175 Joachimiak MP. Zinc against COVID-19? Symptom surveillance and deficiency risk groups. PLoS Negl Trop Dis 2021;15:e0008895. [PMID: 33395417 DOI: 10.1371/journal.pntd.0008895] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
176 Song Y, Gao P, Ran T, Qian H, Guo F, Chang L, Wu W, Zhang S. High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19. Front Cardiovasc Med 2020;7:128. [PMID: 32733921 DOI: 10.3389/fcvm.2020.00128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
177 Wang J, Yang W, Chen P, Guo J, Liu R, Wen P, Li K, Lu Y, Ma T, Li X, Qin S, Zhang Y, Wang Y. The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis. PLoS One 2021;16:e0249481. [PMID: 33882090 DOI: 10.1371/journal.pone.0249481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
178 Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT. Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. J Eur Acad Dermatol Venereol 2020;34:e302-3. [PMID: 32333823 DOI: 10.1111/jdv.16525] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 17.0] [Reference Citation Analysis]
179 Belli LS, Fondevila C, Cortesi PA, Conti S, Karam V, Adam R, Coilly A, Ericzon BG, Loinaz C, Cuervas-Mons V, Zambelli M, Llado L, Diaz-Fontenla F, Invernizzi F, Patrono D, Faitot F, Bhooori S, Pirenne J, Perricone G, Magini G, Castells L, Detry O, Cruchaga PM, Colmenero J, Berrevoet F, Rodriguez G, Ysebaert D, Radenne S, Metselaar H, Morelli C, De Carlis LG, Polak WG, Duvoux C; ELITA-ELTR COVID-19 Registry. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study. Gastroenterology 2021;160:1151-1163.e3. [PMID: 33307029 DOI: 10.1053/j.gastro.2020.11.045] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 17.0] [Reference Citation Analysis]
180 Alesci A, Lauriano ER, Aragona M, Capillo G, Pergolizzi S. Marking vertebrates langerhans cells, from fish to mammals. Acta Histochem 2020;122:151622. [PMID: 33066843 DOI: 10.1016/j.acthis.2020.151622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
181 Noordzij M, Duivenvoorden R, Pena MJ, de Vries H, Kieneker LM; collaborative ERACODA authors. ERACODA: the European database collecting clinical information of patients on kidney replacement therapy with COVID-19. Nephrol Dial Transplant 2020;35:2023-5. [PMID: 32785669 DOI: 10.1093/ndt/gfaa179] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
182 Cardinale F, Ciprandi G, Barberi S, Bernardini R, Caffarelli C, Calvani M, Cavagni G, Galli E, Minasi D, Del Giudice MM, Moschese V, Novembre E, Paravati F, Peroni DG, Tosca MA, Traina G, Tripodi S, Marseglia GL; and the SIAIP Task Force. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital J Pediatr 2020;46:84. [PMID: 32546234 DOI: 10.1186/s13052-020-00843-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
183 Meidaninikjeh S, Sabouni N, Marzouni HZ, Bengar S, Khalili A, Jafari R. Monocytes and macrophages in COVID-19: Friends and foes. Life Sci 2021;269:119010. [PMID: 33454368 DOI: 10.1016/j.lfs.2020.119010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
184 Poshekhontseva VY, Fokina VV, Tarlachkov SV, Machulin AV, Shutov AA, Donova MV. Streptomyces tsukubensis VKM Aс-2618D-an Effective Producer of Tacrolimus. Appl Biochem Microbiol 2021;57:939-48. [PMID: 34924587 DOI: 10.1134/S0003683821090064] [Reference Citation Analysis]
185 Omolo CA, Soni N, Fasiku VO, Mackraj I, Govender T. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus. Eur J Pharmacol. 2020;883:173348. [PMID: 32634438 DOI: 10.1016/j.ejphar.2020.173348] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
186 Christensen EE, Jørgensen MJ, Nore KG, Dahl TB, Yang K, Ranheim T, Huse C, Lind A, Nur S, Stiksrud B, Jenum S, Tonby K, Holter JC, Holten AR, Halvorsen B, Dyrhol-Riise AM. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns. J Intern Med 2021. [PMID: 34080738 DOI: 10.1111/joim.13310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci 2020;50:620-32. [PMID: 32299202 DOI: 10.3906/sag-2004-168] [Cited by in Crossref: 169] [Cited by in F6Publishing: 152] [Article Influence: 84.5] [Reference Citation Analysis]
188 Hong L, Smith N, Keerthy M, Lee-Griffith M, Garcia R, Shaman M, Goyert G. Severe COVID-19 infection in pregnancy requiring intubation without preterm delivery: A case report. Case Rep Womens Health 2020;27:e00217. [PMID: 32382516 DOI: 10.1016/j.crwh.2020.e00217] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
189 Calderone A, Menichetti F, Santini F, Colangelo L, Lucenteforte E, Calderone V. Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option? Front Pharmacol 2020;11:1085. [PMID: 32765279 DOI: 10.3389/fphar.2020.01085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
190 Hanna E. How fragile we are. Head Neck 2020;42:1355-60. [PMID: 32633092 DOI: 10.1002/hed.26366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
191 Jakhmola S, Indari O, Kashyap D, Varshney N, Rani A, Sonkar C, Baral B, Chatterjee S, Das A, Kumar R, Jha HC. Recent updates on COVID-19: A holistic review. Heliyon 2020;6:e05706. [PMID: 33324769 DOI: 10.1016/j.heliyon.2020.e05706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
192 Rana MM. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges. J Biomater Sci Polym Ed 2021;32:1219-49. [PMID: 33787467 DOI: 10.1080/09205063.2021.1909412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
193 Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K. COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen. J Dtsch Dermatol Ges 2020;18:795-809. [PMID: 32881300 DOI: 10.1111/ddg.14169_g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
194 Balestri R, Rech G, Girardelli CR. Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus. J Eur Acad Dermatol Venereol 2020;34:e435-6. [PMID: 32359182 DOI: 10.1111/jdv.16578] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
195 Bonalumi G, Giambuzzi I, Barbone A, Ranieri C, Cavallotti L, Trabattoni P, Naliato M, Polvani G, Torracca L, Pelenghi S, Ragni F, Russo CF, Guerra F, Trimarchi S, Civilini E, Romani F, Bellosta R, Losa S, Roberto M, Alamanni F. A call to action becomes practice: cardiac and vascular surgery during the COVID-19 pandemic based on the Lombardy emergency guidelines. Eur J Cardiothorac Surg 2020;58:319-27. [PMID: 32584978 DOI: 10.1093/ejcts/ezaa204] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
196 Li X, Sun J, Prinz RA, Liu X, Xu X. Inhibition of porcine epidemic diarrhea virus (PEDV) replication by A77 1726 through targeting JAK and Src tyrosine kinases. Virology 2020;551:75-83. [PMID: 32829915 DOI: 10.1016/j.virol.2020.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
197 Garg PK, Kaul P, Choudhary D, Turaga KK, Singh MP, Tiwari AR, Arora V, Agrawal N, Rau B, Yendamuri S. Discordance of COVID-19 guidelines for patients with cancer: A systematic review. J Surg Oncol 2020. [PMID: 32668034 DOI: 10.1002/jso.26110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
198 Borse S, Joshi M, Saggam A, Bhat V, Walia S, Marathe A, Sagar S, Chavan-Gautam P, Girme A, Hingorani L, Tillu G. Ayurveda botanicals in COVID-19 management: An in silico multi-target approach. PLoS One 2021;16:e0248479. [PMID: 34115763 DOI: 10.1371/journal.pone.0248479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
199 Lubetzky M, Aull MJ, Craig-Schapiro R, Lee JR, Marku-Podvorica J, Salinas T, Gingras L, Lee JB, Sultan S, Kodiyanplakkal RP, Hartono C, Saal S, Muthukumar T, Kapur S, Suthanthiran M, Dadhania DM. Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center. Nephrol Dial Transplant 2020;35:1250-61. [PMID: 32678882 DOI: 10.1093/ndt/gfaa154] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
200 Bitaraf E, Ahmadi SAY, Gandomi-Mohammadabadi A, Noorani Mejareh Z, Abdollahi B, Balasi J, Moodi F, Hemmati N, Kabir A. Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study. J Immunol Res 2021;2021:9934134. [PMID: 34307694 DOI: 10.1155/2021/9934134] [Reference Citation Analysis]
201 Mathiasen VD, Oversoe SK, Ott P, Jensen-Fangel S, Leth S. Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression: A Case Report. Transplant Proc 2020;52:2703-6. [PMID: 33039144 DOI: 10.1016/j.transproceed.2020.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
202 Alcock J, Masters A. Cytokine storms, evolution and COVID-19. Evol Med Public Health 2021;9:83-92. [PMID: 34552755 DOI: 10.1093/emph/eoab005] [Reference Citation Analysis]
203 Türsen Ü, Türsen B, Lotti T. Coronavirus-days ın dermatology. Dermatol Ther 2020;33:e13438. [PMID: 32307810 DOI: 10.1111/dth.13438] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
204 Leipe J, Wilke EL, Ebert MP, Teufel A, Reindl W. Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab. Semin Arthritis Rheum 2020;50:1087-8. [PMID: 32916559 DOI: 10.1016/j.semarthrit.2020.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
205 Asgharpour M, Mehdinezhad H, Bayani M, Zavareh MSH, Hamidi SH, Akbari R, Ghadimi R, Bijani A, Mouodi S. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19). BMC Nephrol 2020;21:356. [PMID: 32819292 DOI: 10.1186/s12882-020-02020-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
206 Mohammed El Tabaa M, Mohammed El Tabaa M. Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost. Biochem Pharmacol 2020;178:114057. [PMID: 32470547 DOI: 10.1016/j.bcp.2020.114057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
207 Menshawey R, Menshawey E, Alserr AHK, Abdelmassih AF. JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations. Cardiovasc Endocrinol Metab 2021;10:80-8. [PMID: 34109302 DOI: 10.1097/XCE.0000000000000237] [Reference Citation Analysis]
208 Lisco G, De Tullio A, Giagulli VA, Guastamacchia E, De Pergola G, Triggiani V. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review. Endocrine 2020;70:441-53. [PMID: 32779091 DOI: 10.1007/s12020-020-02444-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
209 López-Iranzo FJ, López-Rodas AM, Franco L, López-Rodas G. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the "Cytokine Release (Storm) Syndrome" Caused by SARS-CoV-2? Curr Pharm Des 2020;26:4515-21. [PMID: 32787748 DOI: 10.2174/1381612826666200811180232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
210 Alfishawy M, Nso N, Nassar M, Ariyaratnam J, Bhuiyan S, Siddiqui RS, Li M, Chung H, Al Balakosy A, Alqassieh A, Fülöp T, Rizzo V, Daoud A, Soliman KM. Liver transplantation during global COVID-19 pandemic. World J Clin Cases 2021; 9(23): 6608-6623 [PMID: 34447809 DOI: 10.12998/wjcc.v9.i23.6608] [Reference Citation Analysis]
211 Abboud H, Zheng C, Kar I, Chen CK, Sau C, Serra A. Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic. Mult Scler Relat Disord 2020;44:102249. [PMID: 32526698 DOI: 10.1016/j.msard.2020.102249] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
212 Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med 2021;10:4015. [PMID: 34501463 DOI: 10.3390/jcm10174015] [Reference Citation Analysis]
213 George I, Salna M, Kobsa S, Deroo S, Kriegel J, Blitzer D, Shea NJ, D'Angelo A, Raza T, Kurlansky P, Takeda K, Takayama H, Bapat V, Naka Y, Smith CR, Bacha E, Argenziano M. The Rapid Transformation of Cardiac Surgery Practice in the Coronavirus Disease 2019 (COVID-19) Pandemic: Insights and Clinical Strategies From a Center at the Epicenter. Ann Thorac Surg 2020;110:1108-18. [PMID: 32591132 DOI: 10.1016/j.athoracsur.2020.04.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
214 England JT, Abdulla A, Biggs CM, Lee AYY, Hay KA, Hoiland RL, Wellington CL, Sekhon M, Jamal S, Shojania K, Chen LYC. Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes. Blood Rev 2021;45:100707. [PMID: 32425294 DOI: 10.1016/j.blre.2020.100707] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 26.5] [Reference Citation Analysis]
215 Singh DD, Han I, Choi EH, Yadav DK. Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2. Comput Struct Biotechnol J 2020;18:3774-87. [PMID: 33235690 DOI: 10.1016/j.csbj.2020.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
216 Cure E, Kucuk A, Cumhur Cure M. Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19). Rheumatol Int 2020;40:1177-9. [PMID: 32415310 DOI: 10.1007/s00296-020-04603-7] [Reference Citation Analysis]
217 Moore N, Carleton B, Blin P, Bosco-Levy P, Droz C. Does Ibuprofen Worsen COVID-19? Drug Saf 2020;43:611-4. [PMID: 32529474 DOI: 10.1007/s40264-020-00953-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
218 Bloomgarden Z. Is the type of diabetes treatment relevant to outcome of COVID-19? J Diabetes 2020;12:486-7. [PMID: 32353193 DOI: 10.1111/1753-0407.13047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
219 Naik RR, Shakya AK. Therapeutic Strategies in the Management of COVID-19. Front Mol Biosci 2020;7:636738. [PMID: 33614709 DOI: 10.3389/fmolb.2020.636738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
220 Beecker J, Papp KA, Dutz J, Vender RB, Gniadecki R, Cooper C, Gisondi P, Gooderham M, Hong CH, Kirchhof MG, Lynde CW, Maari C, Poulin Y, Puig L. Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond. J Eur Acad Dermatol Venereol 2021;35:797-806. [PMID: 33533553 DOI: 10.1111/jdv.17075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
221 George I, Salna M, Kobsa S, Deroo S, Kriegel J, Blitzer D, Shea NJ, D'Angelo A, Raza T, Kurlansky P, Takeda K, Takayama H, Bapat V, Naka Y, Smith CR, Bacha E, Argenziano M. The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: Insights and clinical strategies from a center at the epicenter. J Thorac Cardiovasc Surg 2020;160:937-947.e2. [PMID: 32624303 DOI: 10.1016/j.jtcvs.2020.04.060] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
222 Melody M, Nelson J, Hastings J, Propst J, Smerina M, Mendez J, Guru P. Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019. Immunotherapy 2020;12:1121-6. [PMID: 32546029 DOI: 10.2217/imt-2020-0136] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
223 Hossein-Khannazer N, Shokoohian B, Shpichka A, Aghdaei HA, Timashev P, Vosough M. An update to "novel therapeutic approaches for treatment of COVID-19". J Mol Med (Berl) 2021;99:303-10. [PMID: 33392632 DOI: 10.1007/s00109-020-02027-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
224 Kridin K, Schonmann Y, Solomon A, Damiani G, Tzur Bitan D, Onn E, Weinstein O, Cohen AD. Risk of COVID-19 Infection, Hospitalization, and Mortality in Patients with Psoriasis Treated by Interleukin-17 Inhibitors. J Dermatolog Treat 2021;:1-28. [PMID: 33759683 DOI: 10.1080/09546634.2021.1905766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
225 Alsuliman T, Alasadi L, Alkharat B, Srour M, Alrstom A. A review of potential treatments to date in COVID-19 patients according to the stage of the disease. Curr Res Transl Med 2020;68:93-104. [PMID: 32540367 DOI: 10.1016/j.retram.2020.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
226 Zhyvotovska A, Yusupov D, Foronjy R, Nakeshbandi M, McFarlane SI, Salifu M. Insights into Potential Mechanisms of Injury and Treatment Targets in COVID-19, SARS-Cov-2 Infection. Int J Clin Res Trials 2020;5:147. [PMID: 32676542 DOI: 10.15344/2456-8007/2020/147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
227 Golamari R, Kapoor N, Devaraj T, Sahu N, Kramer C, Jain R. Experimental therapies under investigation for COVID-19. J Community Hosp Intern Med Perspect 2021;11:187-93. [PMID: 33889318 DOI: 10.1080/20009666.2021.1874093] [Reference Citation Analysis]
228 Solinas C, Perra L, Aiello M, Migliori E, Petrosillo N. A critical evaluation of glucocorticoids in the management of severe COVID-19. Cytokine Growth Factor Rev 2020;54:8-23. [PMID: 32616381 DOI: 10.1016/j.cytogfr.2020.06.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
229 Khalefah MM, Khalifah AM. Determining the relationship between SARS-CoV-2 infection, dopamine, and COVID-19 complications. J Taibah Univ Med Sci 2020;15:550-3. [PMID: 33173452 DOI: 10.1016/j.jtumed.2020.10.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
230 Farooqi F, Dhawan N, Morgan R, Dinh J, Nedd K, Yatzkan G. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review. Trop Med Infect Dis 2020;5:E112. [PMID: 32635353 DOI: 10.3390/tropicalmed5030112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
231 Ramírez-de-Arellano A, Gutiérrez-Franco J, Sierra-Diaz E, Pereira-Suárez AL. The role of estradiol in the immune response against COVID-19. Hormones (Athens) 2021. [PMID: 34142358 DOI: 10.1007/s42000-021-00300-7] [Reference Citation Analysis]
232 Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol 2021. [PMID: 33609255 DOI: 10.1007/s12016-021-08848-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 20.0] [Reference Citation Analysis]
233 Caro-Patón GL, de Azagra-Garde AM, García-Salido A, Cabrero-Hernández M, Tamariz A, Nieto-Moro M. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature. J Intensive Care Med 2021;36:392-403. [PMID: 33148089 DOI: 10.1177/0885066620969350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
234 Förster-Ruhrmann U, Szczepek AJ, Bachert C, Olze H. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab. J Allergy Clin Immunol 2020;146:218-220.e2. [PMID: 32417136 DOI: 10.1016/j.jaci.2020.05.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
235 Arca KN, Smith JH, Chiang CC, Starling AJ, Robertson CE, Halker Singh RB, Schwedt TJ, Kissoon NR, Garza I, Rozen TD, Boes CJ, Whealy MA, VanderPluym JH. COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use. Headache 2020;60:1558-68. [PMID: 32648592 DOI: 10.1111/head.13903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
236 Ali MJ, Hanif M, Haider MA, Ahmed MU, Sundas F, Hirani A, Khan IA, Anis K, Karim AH. Treatment Options for COVID-19: A Review. Front Med (Lausanne) 2020;7:480. [PMID: 32850922 DOI: 10.3389/fmed.2020.00480] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]